T-cell Non-Hodgkin's Lymphoma/ T-cell Acute Lymphoblastic Leukmeia Clinical Trials in Houston, Texas

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances